Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ.

A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance. N Engl J Med 2002;346(8):564-9.
Description: Largest analysis of long term prognosis of monoclonal gammopathy of uncertain significance(MGUS)
PubMed citation number: 11856795

Dimopoulos, MA, Moulopoulos, LA, Maniatis, A, Alexanian, R.

Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
Blood 2000; 96:2037-44.
Description: A review of management of solitary plasmacytoma
PubMed citation number: 10979944

Barlogie B. Shaughnessy J. Tricot G. Jacobson J. Zangari M. Anaissie E. Walker R.

Crowley J. Treatment of multiple myeloma.
Blood 2004; 103(1):20-32.
Description: A recent review article of the management of multiple myeloma
PubMed citation number: 12969978

Kuehl WM. Bergsagel PL.

Multiple myeloma: evolving genetic events and host interactions.
Nature Reviews Cancer 2002; 2(3):175-87.
Description: A review of the molecular aspects of multiple myeloma
PubMed citation number: 11990854

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Br J Haematol 2003; 121:749-57.
Description: A recent review of classification of multiple myeloma
PubMed citation number: 12780789

Myeloma Trialists' Collaborative Group.

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials.
J Clin Oncol 1998;16:3832-3842.
Description: Extensive review of the use of chemotherapy for multiple myeloma
PubMed citation number: 9850028

Attal M, Harousseau J-L, Facon T, Guilhot F, Doyen C, Fuzibet JG, Monconduit M, Hulin C, Caillot D, Bouabdallah R, Voillat L, Sotto JJ, Grosbois B, Bataille R.

Single versus double autologous stem-cell transplantation for multiple myeloma.
N Engl J Med 2003;349:2495-2502
Description: Role of single and double transplants in multiple myeloma
PubMed citation number: 14695409

Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B.

Antitumor activity of thalidomide in refractory multiple myeloma.
N Engl J Med 1999;341:1565-1571.
Description: The use of thalidomide in relapsed multiple myeloma
PubMed citation number: 10564685

Richardson P, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC.

A phase 2 study of bortezomib in relapsed, refractory myeloma.
N Engl J Med 2003;348:2609-2617
Description: The use of a novel agent, Velcade, in relapsed multiple myeloma
PubMed citation number: 12826635

Berenson, JR, Hillner, BE, Kyle, RA, Anderson Kj Lipton A, Yee GC, Biermann JS.

American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.
J Clin Oncol 2002; 20:3719-36.
Description: The role of bisphosphonates in bony disease in multiple myeloma
PubMed citation number: 12202673

Dammaco F, Castoldi G, Rodjer S.

Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma.
Br J Haem 2001;113(1):172-9.
Description: The role of erythropoietin in multiple myeloma and its impact on t ransfusion requirements and quality of life
PubMed citation number: 11328297

Dispenzieri A. Kyle RA. Lacy MQ. Rajkumar SV. Therneau TM. Larson DR. Greipp PR. Witzig TE. Basu R. Suarez GA. Fonseca R. Lust JA. Gertz MA.

POEMS syndrome: definitions and long-term outcome.
Blood 2003; 101(7):2496-506.
Description: A review of a series of 99 patients with POEMS syndrome.
PubMed citation number: 12456500

Return to Table of Contents